BTIG analyst David Larsen maintained a Buy rating on CryoPort (CYRX – Research Report) today and set a price target of $33.00. The company’s shares closed yesterday at $16.10.
Larsen covers the Healthcare sector, focusing on stocks such as Evolent Health, Sharecare, and CryoPort. According to TipRanks, Larsen has an average return of -8.4% and a 33.98% success rate on recommended stocks.
In addition to BTIG, CryoPort also received a Buy from B.Riley Financial’s Yuan Zhi in a report issued on July 13. However, on July 17, KeyBanc downgraded CryoPort (NASDAQ: CYRX) to a Hold.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $45.36 and a one-year low of $13.83. Currently, CryoPort has an average volume of 619.8K.
Based on the recent corporate insider activity of 22 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CYRX in relation to earlier this year. Most recently, in May 2023, Robert Stefanovich, the CFO of CYRX sold 19,918.00 shares for a total of $437,000.92.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Read More on CYRX:
